Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial - Wikidata - awgldk - TriplyDB

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial

http://www.wikidata.org/entity/Q33427441

about

Dabigatran approaching the realm of heparin-induced thrombocytopenia Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?Further evidence of the limitations of Activated Partial Thromboplastin Time to monitor Argatroban.Influences of argatroban on five fibrinogen assays.

P2860

Q26744261-18A9E3CA-C3C1-4696-A251-5C473C59673A Q33442600-4048D741-2B1D-4F67-8B69-5957FDFA91A9 Q43065983-F04CB253-2284-458F-8970-EE67B0C4DD0D Q45861270-E47EC361-0F76-403C-A541-B6CCFC4BE2E1 Q48000795-1AC457BC-3C77-4459-909E-64E81B8E06DE

P2860

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial

http://www.wikidata.org/entity/Q33427441

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Argatroban in the management o ...... : a multicenter clinical trial

@ast

Argatroban in the management o ...... : a multicenter clinical trial

@en

type

label

Argatroban in the management o ...... : a multicenter clinical trial

@ast

Argatroban in the management o ...... : a multicenter clinical trial

@en

prefLabel

Argatroban in the management o ...... : a multicenter clinical trial

@ast

Argatroban in the management o ...... : a multicenter clinical trial

@en

P1433

Q33427441-885CBDB6-6071-4F0C-A688-0D257D59ED92

P1476

Q33427441-55211716-63C5-4C8F-A694-592E5185E20F

P2093

Q33427441-0AB7E9DF-0F1B-4EEC-B50F-AA9B251852C5

Q33427441-10587BE2-89E4-47F2-9642-33DB18E98946

Q33427441-150496F0-F85D-4D30-9CE7-C86BC3618797

Q33427441-748BBDA7-C0EC-4149-85EE-F9FEC6608E5D

Q33427441-752C501C-9FB8-4C90-AA00-3016A8741DA8

Q33427441-84806110-AB3D-4E7D-AA5E-1A724F54D377

Q33427441-84C8108A-596D-47EE-AFE9-A1A6E771CE58

Q33427441-8904E636-D98E-4E98-8238-31B10B2AEDA1

Q33427441-A2DC8F71-829C-4E46-A452-4D35DA481AE2

Q33427441-AFDF5D83-1D6A-4D82-AB85-0DC29715C40C

P2860

Q33427441-0754F45A-D58E-4867-8F5D-FFE7C1D098FB

Q33427441-2CE608CA-BF34-45CF-96E0-1FD73920470B

Q33427441-33C9473A-CD28-456F-B860-D27181614270

Q33427441-37E16091-B2A7-49C8-9EAB-F59B1E329558

Q33427441-4D5A0D48-4877-4B41-A724-82E4E98D3195

Q33427441-55E154FF-D7DE-4AD2-8294-1DFFA9385EB8

Q33427441-660BC439-44E7-4C88-8D2F-177BBAF9AAE4

Q33427441-667FA4AC-590B-4616-9677-D89ACCC47F49

Q33427441-6AE9B7FD-A298-48A2-AEF0-C55AA4B16AD7

Q33427441-6FD3542F-154E-433E-BE88-85800CEFE6C1

P2888

Q33427441-AF43994B-9084-43B3-A7E9-6281297D79E6

P304

Q33427441-7330B4A1-83C8-441D-A6ED-EE4B4DA0ADF7

P31

Q33427441-F35C6C43-11F3-4B1E-85C1-B1FC03D1B84A

P356

Q33427441-0F386369-DEC4-45FC-BB15-CA5BEC28C499

P478

Q33427441-7F051222-D4FC-48ED-9B2A-946C194996E3

P577

Q33427441-F63E3CFE-D4CE-4FFA-BFA9-EEE8CEAC4CC6

P5875

Q33427441-AA40E0BC-31EF-4125-9570-FFF39DF82F01

P6179

Q33427441-2D31A781-7163-4B8A-9EDD-D2C1C4F428D6

P698

Q33427441-B8CF0934-7952-40C7-BF5A-45A0BA9CD34F

P921

Q33427441-96F9B936-D75D-44CD-97BE-777A9A986373

Q33427441-C6B10890-11B9-4B27-AC8B-0AC0ABE4D379

P932

Q33427441-915CC350-CF89-494D-BFC5-557F514EE7BF

P356

S13054-015-1109-0

P1433

P1476

Argatroban in the management o ...... : a multicenter clinical trial

@en

P2093

Alain Wynckel

http://www.w3.org/2001/XMLSchema#string

Brigitte Tardy-Poncet

http://www.w3.org/2001/XMLSchema#string

Christine Biron-Andréani

http://www.w3.org/2001/XMLSchema#string

Emmanuel de Maistre

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Thiranos

http://www.w3.org/2001/XMLSchema#string

Judith Villacorta-Torres

http://www.w3.org/2001/XMLSchema#string

Jérome Morel

http://www.w3.org/2001/XMLSchema#string

Lelia Grunebaum

http://www.w3.org/2001/XMLSchema#string

Philippe Nguyen

http://www.w3.org/2001/XMLSchema#string

Pierre-Emmanuel Morange

http://www.w3.org/2001/XMLSchema#string

P2860

Coagulation abnormalities in critically ill patients

Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin

Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004

The ecarin clotting time, a universal method to quantify direct thrombin inhibitors

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia.

Heparin-induced thrombocytopenia: pathogenesis and management.

Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.

Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.

Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.

P2888

s13054-015-1109-0

P304

396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13054-015-1109-0

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283717213

http://www.w3.org/2001/XMLSchema#string

P6179

1001360880

http://www.w3.org/2001/XMLSchema#string

P698

26556106

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

multicenter trial

P932

4641392

http://www.w3.org/2001/XMLSchema#string